[QUOTE=Alan Roehrich;698853]
Quote:
Originally Posted by Jeff Niceswanger
I just noticed this Billy. Here again, the devil is in the details. Yes, Trump signed an executive order to lower prices. But it was only at health centers. Medicare health centers. I don't know that we even have one in our town. Not drug stores. So it did not affect someone like me. Bidens plan lowers the price ...period. No matter where its purchased from. My Albuterol Inhaler was 85 bucks through my drug card. It's now 35 so I'm assuming it got lowered to.
"For Trump?s part, the former president signed an executive order in the last year of his administration requiring federal community health centers to pass on insulin discounts to customers, his own effort to lower insulin prices. Biden later paused that policy when he took office as part of a larger freeze to allow his administration to review new regulations set to go into effect".
I'm assuming Trump did all he could without legislation. Bidens Affordable Care act lowered the prices across the board.[B/QUOTE]
Biden's Affordable Care Act?
|
You got me Alan,
Its the Affordable Insulin Now Act..... and then later Inflation Reduction Act
Affordable Insulin Now Act
This bill limits cost-sharing for insulin under private health insurance and the Medicare prescription drug benefit.
Specifically, the bill caps cost-sharing under private health insurance for a month's supply of selected insulin products at $35 or 25% of a plan's negotiated price (after any price concessions), whichever is less, beginning in 2023.
The bill caps cost-sharing under the Medicare prescription drug benefit for a month's supply of covered insulin products at (1) $35 between October 1, 2022, and January 1, 2024; and (2) $35 or 25% of a plan's negotiated price, whichever is less, beginning in 2024. The bill provides funds for FY2022 for the Centers for Medicare & Medicaid Services (CMS) to implement the bill.
And the other part.......
The price cap for Medicare recipients was part of the Inflation Reduction Act, which originally sought to cap insulin at $35 for all those with health insurance. When it passed in 2022, it was scaled back by congressional Republicans to apply only to older adults.
The Biden administration has also announced agreements with drugmakers Sanofi, Novo Nordisk and Eli Lilly, to cap insulin co-payments at $35 for those with private insurance. They account for more than 90% of the U.S. insulin market.